Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

MED PEER ANALYSIS

MEDIFAST INC — metric-by-metric comparison with peers and the industry median

MEDMEDIFAST INC

🇺🇸 USA · NYSE · Consumer Cyclical · Personal Services

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Personal Services

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
MEDIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
MED-24.3%DESA+13.0%INTEM+50.8%MNDTR+0.0%MERIT+21.4%ARSAN+50.6%
Year-to-Date (YTD)
MED+3.4%DESA-2.1%INTEM-0.4%MNDTR-13.4%MERIT+0.6%ARSAN-8.2%
1-Year
Split-adjusted
MED-24.3%CSV-17.6%
Year-to-Date (YTD)
MED+3.4%CSV-9.1%

Key Metric Comparison

P/E

Lower is better
MED—DESA9.43INTEM191.31MNDTR—MERIT7.92ARSAN—Median 19.64

ROE

Higher is better
MED-9.8%DESA15.4%INTEM3.5%MNDTR-21.9%MERIT5.1%ARSAN-0.4%Median 28.3%

Net Margin

Higher is better
MED-5.8%DESA14.2%INTEM1.4%MNDTR-10.1%MERIT224.2%ARSAN-19.1%Median 12.3%

Revenue Growth

Higher is better
MED-36.3%DESA2.5%INTEM14.8%MNDTR7.8%MERIT68.0%ARSAN63.2%Median 5.4%

P/E

Lower is better
MED—CSV13.82Median 19.64

ROE

Higher is better
MED-9.8%CSV17.9%Median 28.3%

Net Margin

Higher is better
MED-5.8%CSV10.6%Median 12.3%

Revenue Growth

Higher is better
MED-36.3%CSV2.1%Median 5.4%

All Metrics

Valuation
MetricMEDDESAINTEMMNDTRMERITARSANInd. Median
P/E—9.43191.31—7.92●—19.64
P/B0.611.245.810.750.32●0.483.62
EV/EBITDA-4.94●3.1211.9719.8928.9910.6512.12
P/S0.35●1.342.640.3617.7526.301.45
Financial Health
MetricMEDDESAINTEMMNDTRMERITARSANInd. Median
Current Ratio4.803.141.251.367.94●2.951.00
Debt/Equity8.1%8.0%9.1%14.6%0.0%●2.8%163.5%
NetDebt/EBITDA-24.11●-1.200.132.76-0.03-2.991.12
Profitability
MetricMEDDESAINTEMMNDTRMERITARSANInd. Median
Net Margin-5.8%14.2%1.4%-10.1%224.2%●-19.1%12.3%
ROE-9.8%15.4%●3.5%-21.9%5.1%-0.4%28.3%
ROA-7.5%11.4%●0.8%-13.6%5.1%-0.4%5.0%
EBITDA Margin1.8%31.1%22.3%2.1%61.2%192.8%●24.5%
Growth + Dividend
MetricMEDDESAINTEMMNDTRMERITARSANInd. Median
Rev. Growth-36.3%2.5%14.8%7.8%68.0%●63.2%5.4%
NI Growth—6.9%——91.2%●—14.1%
Div. Yield0.2%2.1%●0.0%0.0%0.9%0.0%1.7%
Payout-1.5%19.4%0.0%0.0%7.0%0.0%28.1%
Valuation
MetricMEDCSVInd. Median
P/E—13.8219.64
P/B0.61●2.263.62
EV/EBITDA-4.94●10.0312.12
P/S0.35●1.451.45
Financial Health
MetricMEDCSVInd. Median
Current Ratio4.80●1.151.00
Debt/Equity8.1%●204.6%163.5%
NetDebt/EBITDA-24.11●4.751.12
Profitability
MetricMEDCSVInd. Median
Net Margin-5.8%10.6%●12.3%
ROE-9.8%17.9%●28.3%
ROA-7.5%3.4%●5.0%
EBITDA Margin1.8%27.5%●24.5%
Growth + Dividend
MetricMEDCSVInd. Median
Rev. Growth-36.3%2.1%●5.4%
NI Growth—-6.2%14.1%
Div. Yield0.2%1.2%●1.7%
Payout-1.5%16.1%28.1%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on MED

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.